Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot
Code deleted, see 81200-81479

Official Description

Molecular diagnostics; enzymatic digestion, each enzyme treatment

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Molecular diagnostics encompass a range of tests designed to identify genetic mutations that may indicate the presence of specific diseases, even in the absence of symptoms. These tests play a crucial role in the monitoring and diagnosis of existing disease states, as well as in screening individuals who may be carriers of genetic conditions or those predisposed to certain diseases, thereby facilitating preventive medical interventions. The process involves the preparation of nucleic acids, which can include various forms such as undigested nucleic acids, digestates, or specially modified samples like newly synthesized oligonucleotides. In the context of enzymatic digestion, as described by CPT® Code 83892, the extracted nucleic acid strands undergo modification through the application of enzymes. This enzymatic treatment serves to either degrade or hybridize the nucleic acid strands, allowing for a comparison with a normal reference strand. It is important to note that CPT® Code 83892 is specifically reported for each enzyme treatment performed during this process, highlighting the procedural specificity and the need for accurate coding in molecular diagnostics.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The indications for performing enzymatic digestion as described by CPT® Code 83892 include the following:

  • Genetic Mutation Detection Molecular diagnostic tests are utilized to identify genetic mutations that may indicate the presence of certain diseases, even when the patient exhibits no symptoms.
  • Monitoring Disease States These tests can be employed to monitor existing disease conditions, providing valuable information regarding the progression or status of the disease.
  • Screening for Genetic Carriers The procedure is also indicated for screening individuals who may be carriers of genetic diseases, helping to identify those who could pass on genetic conditions to their offspring.
  • Identifying Predisposition to Conditions Enzymatic digestion may be indicated for individuals who are predisposed to certain diseases, allowing for early intervention and preventive medicine strategies.

2. Procedure

The procedure for enzymatic digestion, as outlined by CPT® Code 83892, involves several key steps:

  • Step 1: Nucleic Acid Extraction The first step involves the extraction of nucleic acids from the biological sample. This process is critical as it isolates the genetic material necessary for subsequent analysis.
  • Step 2: Enzymatic Treatment Following extraction, the nucleic acid strands undergo enzymatic treatment. This step is where specific enzymes are applied to modify the nucleic acids, either by degrading them or facilitating hybridization with reference strands. The choice of enzyme and the conditions of the treatment are tailored to the specific requirements of the analysis.
  • Step 3: Comparison to Reference Strand After enzymatic digestion, the modified nucleic acid strands are compared to a normal reference strand. This comparison is essential for identifying any genetic mutations or abnormalities present in the sample.
  • Step 4: Reporting Finally, the results of the enzymatic digestion and the comparison analysis are documented. CPT® Code 83892 is reported for each enzyme treatment performed, ensuring accurate coding and billing for the services rendered.

3. Post-Procedure

Post-procedure care following enzymatic digestion typically involves the analysis and interpretation of the results obtained from the nucleic acid comparison. Healthcare professionals may need to discuss the findings with the patient, including any implications for diagnosis, treatment options, or further testing that may be required. Additionally, proper documentation of the procedure and results is essential for compliance and billing purposes. There are no specific recovery requirements associated with this procedure, as it is primarily a laboratory-based analysis rather than an invasive procedure.

Short Descr MOLECULAR DIAGNOSTICS
Medium Descr MOLEC ENZYMATIC DIGESTION EA ENZYME TX
Long Descr Molecular diagnostics; enzymatic digestion, each enzyme treatment
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Discontinued Code
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) none
MUE Not applicable/unspecified.
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
Date
Action
Notes
2013-01-01 Deleted Code deleted, see 81200-81479
2009-01-01 Changed Code description changed
1993-01-01 Added Code added.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"